Paclitaxel- versus sirolimus-eluting stents for unprotected left main coronary artery disease.

@article{Mehilli2009PaclitaxelVS,
  title={Paclitaxel- versus sirolimus-eluting stents for unprotected left main coronary artery disease.},
  author={Julinda Mehilli and Adnan Kastrati and Robert A. Byrne and Olga Bruskina and Raisuke Iijima and Stefanie Schulz and J{\"u}rgen Pache and Melchior Seyfarth and Steffen Massberg and Karl-Ludwig Laugwitz and Josef Dirschinger and Albert Schoemig},
  journal={Journal of the American College of Cardiology},
  year={2009},
  volume={53 19},
  pages={1760-8}
}
OBJECTIVES The aim of this trial was to compare the safety and efficacy of paclitaxel-eluting stents (PES) and sirolimus-eluting stents (SES) for treatment of unprotected left main coronary artery (uLMCA) disease. BACKGROUND Both PES and SES have reduced the risk of restenosis, particularly in high-risk patient and lesion subsets. However, their comparative performance in uLMCA lesions is not known. METHODS In this randomized study, 607 patients with symptomatic coronary artery disease… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 72 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 36 references

A meta - analysis of 16 randomized trials of sirolimus - eluting stents versus paclitaxel - eluting stents in patients with coronary artery disease

  • A Schömig, A Dibra, S Windecker
  • J Am Coll Cardiol
  • 2007

A randomized comparison of paclitaxel - eluting stents versus bare - metal stents for treatment of unprotected left main coronary artery stenosis

  • BK Lee, MK Hong, CW Lee
  • J Am Coll Cardiol
  • 2007

Similar Papers

Loading similar papers…